International Medical Affairs Lead / Director
- As International Medical Affairs Lead for Bone Metabolism, you will have an incredible opportunity to lead the medical affairs activities that will improve the lives of patients with X-Linked Hypophosphatemia (XLH) - a rare genetic disorder of phosphate metabolism.
- You will be responsible for the international launch of Burosumab, a fully humanised monoclonal antibody against the phosphaturic hormone - fibroblast growth factor 23 (FGF23).
- An application has been made for conditional approval in Europe and you will be integral in its success, which will change the lives of patients living with this disabling condition.
- You will be in a position to demonstrate true leadership; providing strategic direction to our European affiliates as well as liaising with Japanese colleagues to develop, coordinate and implement International Medical Affairs activities in support of the introduction of a first in class rare disease treatment.
- Our parent company has a product pipeline that will lead to an expanded product portfolio that offers real prospects for continued personal development.
Key Responsibilities will include:
- Representing company's medical interests in interactions with our US-based development partner, commercial teams and payer/market access partners.
- The launch and post launch medical communications strategy including MSL strategy, publications and congress activity.
- Engagement with key stakeholders including external experts and patient organisations.
- Provision of disease and product based education for internal and external customers.
- Develop and lead an Early Access programme.
- Lead and deliver a lifecycle management strategy; encompassing clinical development, investigator sponsored trial program and real world evidence generation.
- As the medical lead ensure the position of affiliate based colleagues is communicated to HQ based functions e.g. regulatory, QA and drug safety.
- To excel in this role you will be a pharmaceutical physician with significant industry experience and proven Medical Affairs experience across the EU.
- A background in rare diseases, including launch phase and development experience is desirable.
- A comprehensive understanding of Industry medical and financial governance norms, with particular reference to compliance, regulations and codes of scientific and Promotional Practice will be required.
- Crucially you will show an ability to influence international cross functional teams and stakeholders and have a can-do, roll your sleeves up and get the job done outlook.
- With our impressive continued growth and enviable product pipeline we would also be interested to connect with Medical Affairs professionals with Therapeutic Area expertise in Oncology / Oncology Support, who may also be interested in opportunities within our European affiliates.
- Headquartered in the UK with affiliate businesses across Europe and the US, our product portfolio focuses in the therapeutic areas of Rare Diseases, Oncology/Oncology supportive care, Nephrology and CNS.